FIELD: biotechnology, microbiology, genetic engineering, molecular biology.
SUBSTANCE: invention relates to a method for preparing anthrax protective antigenic protein (PA). Protective antigenic protein is prepared by using the modified E. coli culture in its culturing with feeding. E. coli cells are transformed with the recombinant constitutive expression plasmid DH5α comprising PA gene to obtain E. coli DH5α cells expressing the protein PA. After culturing high density cells are selected, solubilized with 6-8 M urea and separated by centrifugation. Urea-denaturated PA is isolated from supernatant, purified and eluted. Also, method describes anthrax PA as 6X-histidine-fused protein prepared by this method. In culturing method involves using the primary additive chosen from the group consisting of polythiol, carbohydrate and organic acid, and LB medium (Luria broth) is used for feeding beginning from middle log-phase. As a plasmid for transformation of E. coli cells method involves vector of series pQE comprising phage promoter recognized by E. coli cells. Using the invention provides enhancing the level for producing anthrax protective antigen wherein antigen is obtained in form of protein fused with 6X-histidine.
EFFECT: improved preparing method, high level of antigen.
13 cl, 3 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING NONTOXIC ANTI-ANTHRAX VACCINE | 2002 |
|
RU2287581C2 |
E. COLI STRAIN - PRODUCER OF ISOLATED DOMAIN 1 OF PROTECTIVE BACILLUS ANTHRACIS ANTIGEN IN FORM OF VIRUS-LIKE PARTICLES | 2016 |
|
RU2633508C1 |
IMMUNOGENIC POLYPEPTIDE INDUCING PROTECTIVE IMMUNE RESPONSE AGAINST BACILLUS ANTHRACIS (VARIANTS), METHOD FOR ITS PREPARING, NUCLEIC ACID ENCODING THEREOF, EXPRESSION VECTOR (VARIANTS), METHOD AND VACCINE FOR PROPHYLAXIS OF INFECTION CAUSED BY BACILLUS ANTHRACIS | 2001 |
|
RU2270865C2 |
DNA-STRUCTURE ENCODING MODIFIED VERSION OF PROTECTIVE ANTIGENE BACILLUS ANTHRACIS | 2015 |
|
RU2622085C2 |
HYBRID PROTEIN-BASED POLYVALENT INFLUENZA VACCINE | 2013 |
|
RU2531235C2 |
ECOLI STRAIN - PRODUCER OF FULL-DIMENSIONAL PROTECTIVE BACILLUS ANTHRACIS ANTIGEN IN FORM OF VIRUS-LIKE PARTICLES | 2016 |
|
RU2633504C1 |
WAY OF RECEPTION FUNCTIONALLY ACTIVE RECOMBINANT PROTEIN OF ULCER (LF) LETHAL FACTOR, RECOMBINANT PLASMIDE DNA pETHIS-LF CODING ACTIVE PROTEIN LF; H STRAIN ESCHERICHIA COLI BL-HISLF PRODUCING ACTIVE PROTEIN OF MALIGNANT ANTHRAX LETHAL FACTOR | 2007 |
|
RU2361921C1 |
METHOD OF PRODUCING FUNCTIONALLY ACTIVE RECOMBINANT PROTEIN OF LETHAL FACTOR ANTHRAX (LF), RECOMBINANT PLASMID DNA pETGST-LFmin, ENCODING ACTIVE LF PROTEIN AND STRAIN OF Escherichia coli BL-GSTLFmin, PRODUCING ACTIVE PROTEIN OF LETHAL FACTOR ANTHRAX | 2007 |
|
RU2355769C1 |
RECOMBINANT PLASMID DNA PRO PF5 DETERMINING SYNTHESIS OF CAPSULE ANTIGEN FI OF PLAGUE PATHOGEN AND PROTECTIVE ANTIGEN OF ANTHRAX PATHOGEN AND A METHOD OF CONSTRUCTION OF RECOMBINANT PLASMID DNA PRO PF5 | 1995 |
|
RU2110575C1 |
RECOMBINANT PLASMID pPA-OPRFI DNA CODING HYBRID RECOMBINANT F-I PROTEIN OF Pseudomonas aeruginosa OUTER MEMBRANE, STRAIN Escherichia coli PA-OPRFI PRODUCING HYBRID RECOMBINANT F-I PROTEIN OF Pseudomonas aeruginosa OUTER MEMBRANE AND METHOD FOR PRODUCING HYBRID RECOMBINANT F-I PROTEIN OF Pseudomonas aeruginosa OUTER MEMBRANE | 2011 |
|
RU2537006C2 |
Authors
Dates
2006-11-27—Published
2001-12-07—Filed